Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin

Abstract

Conformation-specific anti-TTR antibodies selectively bind amyloidogenic but not native TTR. These novel antibodies may be therapeutically useful in preventing deposition and promoting clearance of TTR amyloid and in diagnosing TTR amyloidosis.